On this page of Benford's Law Stocks.com we present our study of KAIROS PHARMA LTD. — ticker symbol KAPA. SEC filings have been screened by our Benford's Law software, for quarterly 10Q and annual 10K filings from 11/14/2024 to 5/13/2026 for KAIROS PHARMA LTD. under CIK number 0001962011. For filings made in XBRL (eXtensible Business Reporting Language) format, our algorithm extracts all "tagged" numbers presented by the company; for any non-XBRL filings our algorithm uses its own interal set of rules to extract what it believes to be numbers as found throughout the filings. The format found for each filing is presented below together with the results for KAPA, with the percentage of found numbers beginning with each digit (1's, 2's, 3's, 4's, 5's, 6's, 7's, 8's, and 9's) charted against the "normal" range observed throughout our coverage universe, as well as the "normal" range for KAIROS PHARMA LTD. based on the past KAPA filings our system processed in the past.
33.4
15.2
8.8
16.2
8.4
5.1
5.4
4.7
2.7
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
XBRL?   [ original filing, KAPA stockholder letter ]
Total numbers found: 296
Recent share count: 21,411,198 (2's column)

= Typical range across full coverage universe
Benford's Law Stocks Indicator
296
Low count compared to other filers, falling in the bottom quartile. At this number count, it would take about 3 numbers to move any given column by a full percentage point.
67

Starting from a possible score of 100, we made the following score deductions:
 • We deducted point upon observing the 3's percentage was below the typical coverage universe range.
 • We deducted points upon observing the 3's percentage was below the company's typical historical range.
 • The 4's percentage was higher than the 3's percentage, increasing the penalty multiplier.
 • We deducted points (includes the impact of penalty multiplier) upon observing the 4's percentage was above the typical coverage universe range.
 • We deducted points (includes the impact of penalty multiplier) upon observing the 4's percentage was above the company's typical historical range.
 • The 7's percentage was higher than the 6's percentage, increasing the penalty multiplier.
 • This is the 2nd column with percentage higher than the prior column, resulting in a penalty deduction.
 • We deducted point upon observing the 9's percentage was below the typical coverage universe range.
 • We deducted point upon observing the 9's percentage was below the company's typical historical range.
Benford's Law Stocks Indicator
KAPA
Normal-to-low score compared to other filers, falling within the bottom of the middle 50%.
Check our work! We provide our KAIROS PHARMA LTD. Benford's Law analysis for informational purposes only, and our software should be expected to make mistakes and contain errors (nothing you see on this website should be relied upon for any decision-making without first repeating the analysis yourself independently), and so below we present to you all of the numbers our system detected, for the KAPA filing above. This way, you can open the filing on your own and compare what you see below against what you yourself find. This can also be helpful for exploring any columns in particular that caught your eye.

1's 2's 3's
We found 99 numbers that start with the digit 1. Here they are:
143
1,279
1,091
1,301
1,153
199
199
100,000,000
15,916
14,262
1,006
1,690
1,266
1,690
1,266
1,654
1,262
15,875,485
14,262
1,654
1,654
15,916
13,736,597
14
13,577
13,736,597
14
13,577
1,262
1,262
16,376,118
16
17,193
10,077
16,376,118
16
17,193
10,077
1,654
1,262
17
191
187
1,036
165
1,272
156
18
1,654
1,036
113,599
1,091
1,091
18
188
1,279
1,756
1,756
1,131
1,377
1,091
1,091
18
188
1,279
1.399
1.40
1.40
1,650,000
1.05
1.05
1.48
1.48
1.48
17,850
17,850
1.23
1.40
1.40
108,500
108,500
1.48
1.48
10
150
1,500
10
150
1,500
100,000
1,143
160
15
163
101
105
1,654
1,262
160
We found 45 numbers that start with the digit 2. Here they are:
21,411,198
22
20,000,000
21,411,198
20,821,353
21
21
21,208
20,582
21,010,132
20,821,353
21
20,582
259
259
21,411,198
21
21,208
2,010,000
2
2
220
259
220
2,344
22
206
220
200
200
225
206
2,500,000
2,500,000
259
259
2.40
2
250
250
250
2,500
2,000
2
259
We found 26 numbers that start with the digit 3. Here they are:
3,675
36
36
367
367
3,056
3,056
385
3,058
3,058
3,675
3,616
328
3,675
3,612
30,000
3.0
385
367
3,750,000
3,500
3,058
3.75
35
35
36
4's 5's 6's
We found 48 numbers that start with the digit 4. Here they are:
4,491
4,443
431
431
493
4
4
4,776
4,776
484
484
40
40
4,491
41
4,326
40
4,281,038
4,543,188
4,656,787
400
4,500
4,500
4,281,038
40
4.80
4,281,038
40
4.80
4,281,038
40
4.80
40
46
46
46
4,154,688
4,154,688
4.80
4.80
4.80
40
4.80
4,281,038
4,281,038
4.25
448
4
We found 25 numbers that start with the digit 5. Here they are:
51
5,387
5,744
5,313
5,744
589,845
5,313
551,000
5,053,643
500
589,845
554
554
5
5
500
5,000
50
500
5
5
50,000
50,000
562
536
We found 15 numbers that start with the digit 6. Here they are:
625
62
6,540
6,341
6,540
684
6,341
636
62
625
625
625
670,641
61
621
7's 8's 9's
We found 16 numbers that start with the digit 7. Here they are:
773
78,521
76
76
7,132
7,132
76
714
772,605
75,000
75,000
772,605
772,605
76
76
783
We found 14 numbers that start with the digit 8. Here they are:
845
8,815
8,815
816
800
845
856
856
845
80
856
877,395
813
85
We found 8 numbers that start with the digit 9. Here they are:
92
900
900
911
900
900
900
9
While the above KAPA 10Q Filed 5/13/2026 is interesting in isolation, we have found that it is also useful to take a look at older KAIROS PHARMA LTD. filings processed by our Benford's Law Stocks algorithm, to see how the company's filings "typically look" on a Benford's Law analysis. Below we repeat the 10Q Filed 5/13/2026 but instead of the chart comparing against the typical company across our coverage universe, below we show the same chart compared against the typical KAPA 10Q and 10K filings that we have processed historically. This is followed by similar charts for each of those historical filings.

33.4
15.2
8.8
16.2
8.4
5.1
5.4
4.7
2.7
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 67
XBRL?   [ original filing ]
Total numbers found: 296

= Typical KAPA range from 11/14/2024 to 5/13/2026
33.1
19.2
14.9
9.8
9.8
4.3
2.0
2.8
4.0
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 81
XBRL?   [ original filing ]
Total numbers found: 396

= Typical KAPA range from 11/14/2024 to 5/13/2026
33.5
13.7
13.7
10.2
11.2
5.8
4.2
4.2
3.5
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 91
XBRL?   [ original filing ]
Total numbers found: 430

= Typical KAPA range from 11/14/2024 to 5/13/2026
27.1
18.7
12.9
13.5
10.6
5.6
3.8
4.4
3.4
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 82
XBRL?   [ original filing ]
Total numbers found: 502

= Typical KAPA range from 11/14/2024 to 5/13/2026
30.4
16.1
14.6
12.7
8.7
3.1
6.2
3.7
4.3
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 82
XBRL?   [ original filing ]
Total numbers found: 322

= Typical KAPA range from 11/14/2024 to 5/13/2026
32.7
17.3
14.7
12.1
8.3
3.3
4.6
3.9
3.1
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 94
XBRL?   [ original filing ]
Total numbers found: 456

= Typical KAPA range from 11/14/2024 to 5/13/2026
29.0
16.8
10.0
12.4
9.6
5.8
3.2
6.6
6.6
 
%1 %2 %3 %4 %5 %6 %7 %8 %9
Benford's Law Stocks Score: 57
XBRL?   [ original filing ]
Total numbers found: 469

= Typical KAPA range from 11/14/2024 to 5/13/2026
 

Benford's Law KAPA Stock (KAIROS PHARMA LTD.) | www.Benford'sLawStocks.com
Copyright © 2023 - 2026, All Rights Reserved

Nothing in BenfordsLawStocks.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.